Lyumjev® (insulin lispro-aabc) - Eli Lilly and Company

Lyumjev ® and Humalog ® are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates. This site is intended for US residents ages 18 and …

CouponFollow Extension

FAQs about Lyumjev® (insulin lispro-aabc) - Eli Lilly and Company Coupon?

What is Lyumjev (insulin lispro)?

Lyumjev is a novel formulation of insulin lispro. It is designed to speed the absorption of insulin into the bloodstream and reduce A1C levels in adults with diabetes. In clinical studies, Lyumjev provided superior reduction in blood sugar spikes compared with Humalog ® (insulin lispro injection) when blood sugar was measured 1 and 2 hours after a meal. ...

Can I take lyumjev If I have diabetes?

Do not take Lyumjev if you have : an allergy to insulin lispro-aabc or any of the ingredients in Lyumjev. When you have diabetes, your body is not able to effectively make or use insulin it needs to control blood sugar levels. ...

Is lyumjev included in the Lilly insulin value program?

For people without insurance coverage, Lyumjev is included in the Lilly Insulin Value Program for $35. To access this offer, call the Lilly Diabetes Solution Center at (833) 808-1234. Operators are available Monday through Friday from 8 a.m. to 8 p.m. (ET). ...

How does lyumjev work?

Lyumjev is a fast-acting mealtime insulin that works to help control blood sugar spikes after you eat, similar to how natural insulin works after meals in people without diabetes. Do not reuse needles or share your insulin injection supplies with other people. This includes your: You or the other person can get a serious infection. ...

Can you take lyumjev with a syringe?

Do not use a syringe to remove Lyumjev from your prefilled pen. This can cause you to take too much insulin. Taking too much insulin can lead to severe low blood sugar. This may result in seizures or death. Prefer to take your Lyumjev another way? Lyumjev U-100 is also available in a vial and can be given with a U-100 insulin syringe. ...

Does lyumjev work in pediatric patients with Type 1 diabetes?

5 Pediatric Patients with Type 1 DiabetesPRONTO-Peds (NCT03740919) was a 26-week, randomized (2:2:1), active controlled, treat-to-target, multinational trial that evaluated the efficacy of LYUMJEV in 716 pediatric patients with type 1 diabetes. Patients were randomized to eith ...